右冠状动脉周围脂肪CT衰减在高危斑块、斑块体积及缺血之外的预后价值
本研究纳入539例疑似冠心病患者,均行CCTA和[15O]H2O PET灌注成像,评估PCATa在定量斑块体积和PET缺血之外的预后价值。中位随访5.0年发生33例终点事件,RCA PCATa高于扫描仪特异性阈值与更差预后相关(未校正HR 2.84),校正影像变量和临床特征后仍保留预后价值(校正HR 2.45)。动脉粥样硬化负荷和缺血相关参数与结局的关联强于RCA PCATa,但RCA PCATa提供了额外预后信息。
要点
- RCA PCATa高于扫描仪特异性阈值时预后更差,校正斑块体积和缺血后仍有独立预后价值。
- LAD和LCx的PCATa与结局无关,仅RCA PCATa有预后意义。
- 斑块体积和缺血参数与结局的关联强于RCA PCATa,后者为补充而非替代。
关键影像表现/征象
- RCA PCATa高于扫描仪特异性阈值与更差预后相关(未校正HR 2.84,95%CI 1.44–5.63,P=0.003)。
- LAD和LCx的PCATa与结局无关。
- CACS>59 Agatston单位、阻塞性CAD、高危斑块、TPV>220 mm3、CPV>110 mm3、NCPV>85 mm3和心肌缺血均与更短终点时间相关(未校正HR 4.17、4.88、3.41、7.91、5.82、8.07、4.25,P均<0.05)。
诊断标准与关键数值
- RCA PCATa以扫描仪特异性阈值判断,高于阈值者预后更差(未校正HR 2.84,95%CI 1.44–5.63,P=0.003;校正HR 2.45,95%CI 1.23–4.93,P=0.011)。
- CACS>59 Agatston单位与更短终点时间相关(未校正HR 4.17,95%CI 1.80–9.64)。
- TPV>220 mm3(未校正HR 7.91,95%CI 3.05–20.49)、CPV>110 mm3(未校正HR 5.82,95%CI 2.40–14.10)、NCPV>85 mm3(未校正HR 8.07,95%CI 3.33–19.55)与更短终点时间相关。
- 阻塞性CAD(≥50%狭窄)未校正HR 4.88(95%CI 1.88–12.65),高危斑块未校正HR 3.41(95%CI 1.72–6.75),心肌缺血未校正HR 4.25(95%CI 1.84–9.78)。
临床应用与阅片要点
- 阅片时可关注RCA近段PCATa,高于扫描仪特异性阈值提示额外预后风险,可写入报告作为风险分层补充。
- PCATa的预后价值独立于斑块体积和缺血,但斑块负荷和缺血参数关联更强,报告应以斑块和缺血评估为主、PCATa为辅。
- LAD和LCx的PCATa在本研究中与结局无关,不宜据此推断其预后意义。
局限性
- 单中心研究,样本量539例,终点事件仅33例,事件数较少。
- PCATa阈值需按扫描仪特异性确定,结果外推到其他扫描仪需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study was designed to assess the prognostic value of pericoronary adipose tissue computed tomography attenuation (PCATa) beyond quantitative coronary computed tomography angiography (CCTA)-derived plaque volume and positron emission tomography (PET) determined ischemia.
BACKGROUND: Inflammation plays a crucial role in atherosclerosis. PCATa has been shown to assess coronary-specific inflammation and is of prognostic value in patients with suspected coronary artery disease (CAD).
METHODS: A total of 539 patients who underwent CCTA and [15O]H2O PET perfusion imaging because of suspected CAD were included. Imaging assessment included coronary artery calcium score (CACS), presence of obstructive CAD (≥50% stenosis) and high-risk plaques (HRPs), total plaque volume (TPV), calcified/noncalcified plaque volume (CPV/NCPV), PCATa, and myocardial ischemia. The endpoint was a composite of death and nonfatal myocardial infarction. Prognostic thresholds were determined for quantitative CCTA variables.
RESULTS: During a median follow-up of 5.0 (interquartile range: 4.7 to 5.0) years, 33 events occurred. CACS >59 Agatston units, obstructive CAD, HRPs, TPV >220 mm3, CPV >110 mm3, NCPV >85 mm3, and myocardial ischemia were associated with shorter time to the endpoint with unadjusted hazard ratios (HRs) of 4.17 (95% confidence interval [CI]: 1.80 to 9.64), 4.88 (95% CI: 1.88 to 12.65), 3.41 (95% CI: 1.72 to 6.75), 7.91 (95% CI: 3.05 to 20.49), 5.82 (95% CI: 2.40 to 14.10), 8.07 (95% CI: 3.33 to 19.55), and 4.25 (95% CI: 1.84 to 9.78), respectively (p < 0.05 for all). Right coronary artery (RCA) PCATa above scanner specific thresholds was associated with worse prognosis (unadjusted HR: 2.84; 95% CI: 1.44 to 5.63; p = 0.003), whereas left anterior descending artery and circumflex artery PCATa were not related to outcome. RCA PCATa above scanner specific thresholds retained is prognostic value adjusted for imaging variables and clinical characteristics associated with the endpoint (adjusted HR: 2.45; 95% CI: 1.23 to 4.93; p = 0.011).
CONCLUSIONS: Parameters associated with atherosclerotic burden and ischemia were more strongly associated with outcome than RCA PCATa. Nonetheless, RCA PCATa was of prognostic value beyond clinical characteristics, CACS, obstructive CAD, HRPs, TPV, CPV, NCPV, and ischemia.
引用
- van Diemen PA, Bom MJ, Driessen RS, et al. Prognostic Value of RCA Pericoronary Adipose Tissue CT-Attenuation Beyond High-Risk Plaques, Plaque Volume, and Ischemia. JACC Cardiovasc Imaging. 2021. PMID: 33958312. doi:10.1016/j.jcmg.2021.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。